Surgical removal of bleeding in the brain
Official title: Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
Run by Sohag University · NCT06816641 · Data updated 2026-11-12
This study tests if surgically removing bleeding in the brain can help people aged 20 to 70 recover better from a severe type of stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | December 1, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT06816641 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20-70 with radiological findings of spontaneous intracerebral hemorrhage.
✕Probably not a fit
Patients with traumatic ICH, significant comorbidities, or those on anticoagulant therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of surgically removing spontaneous intracerebral hemorrhage (ICH), a severe type of stroke characterized by bleeding within the brain. It focuses on understanding how this intervention impacts clinical outcomes and identifies prognostic factors that may influence recovery. The study includes patients aged 20 to 70 with radiological evidence of ICH, while excluding those with traumatic causes or significant comorbidities. The goal is to improve treatment strategies for ICH and reduce associated mortality rates.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients suffering from spontaneous intracerebral hemorrhage.
How similar studies have gone: Other studies have explored surgical interventions for ICH, showing varying degrees of success, but this specific approach is being assessed for its unique efficacy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with radiological findings of ICH. * Age group 20-70 years. Exclusion Criteria: * • Traumatic ICH or ruptured aneurysm or AVM or brain tumor. * Postoperative cranial surgery ICH. * Secondary hydrocephalus. * Patients with other comorbidities e.g., Liver cell failure and renal cell failure. * Patients with bleeding disorders. * Patients who are regular on anticoagulant or antiplatelet therapy. * Small sized ICH\< 30 ml. * GCS less than 6 preoperatively.
Where it's running
-
Sohag University hospitals
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Mohamed A Ragheb, Demonstrator
- Email: raghibov@gmail.com
- Phone: 01025921006
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Erlangen Stroke Registry: A long-running look at stroke in a German community
This registry is testing how stroke cases are collected and followed over time in Erlangen to understand how many people are affected and how care evolves.
-
Minocycline for moderate acute stroke at Maimonides
This study will see if adding minocycline to standard care helps adults with moderate acute ischemic or hemorrhagic stroke recover better and survive more often.
-
Psilocybin to reopen brain plasticity after chronic stroke
This trial will test whether a supervised dose of psilocybin is safe and can help reopen brain plasticity in adults who had an ischemic or hemorrhagic stroke at least 12 months ago.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.